Treatment Improves Outcomes in Patients With CRSwNP, Features of Obstructive Lung Disease
In the phase 3 SINUS-24 and SINUS-52 trials, dupilumab improved clinical outcomes and and health-related quality of life among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and clinical features of obstructive lung disease.
University Of Pennsylvania Smell Identification Test Pennsylvania Smell Identification Test Sino Nasal Outcome Test Sinus 24 Sinus 52 Obstructive Lung Disease
Source: ajmc.com